First-in-human study of TN-201, an AAV9 gene replacement therapy in MYBPC3-associated hypertrophic cardiomyopathy: initial safety, pharmacodynamic, and imaging results from MyPEAK-1. [PDF]
Desai MY +17 more
europepmc +1 more source
Mosaic AAV mediates efficient transduction across the central and peripheral nervous systems. [PDF]
Jiang M +5 more
europepmc +1 more source
Pervasive horizontal transfer of adeno-associated virus capsid genes. [PDF]
Gifford RJ.
europepmc +1 more source
Compact Calm1 promoter enables AAV mediated neuron-targeted expression in human iPSC-derived brain organoids. [PDF]
Klockner I +4 more
europepmc +1 more source
Transcriptomic Profiling Reveals Divergent Immune Responses to AAV1 and AAV-ie in Mice Inner Ear. [PDF]
Shi D +9 more
europepmc +1 more source
The Impact of QSP Modeling on the Design and Optimization of Gene Therapy Approaches. [PDF]
Rayad N, Chowdhury EA, Meno-Tetang GML.
europepmc +1 more source
Methodological validation of a cryo-TEM-based detection method for empty capsid ratio in recombinant adeno-associated virus. [PDF]
Xu L +11 more
europepmc +1 more source
Frameless intraputaminal delivery of gene therapy with eladocagene exuparvovec in patients with aromatic L-amino acid decarboxylase deficiency: safe and efficient results. [PDF]
Mai R +5 more
europepmc +1 more source
Triple rAAV9 Vector Combinations Encoding Broadly Neutralizing Antibodies Effectively Suppress HIV-1 Infection in Humanized Mice. [PDF]
Leontyev DS +8 more
europepmc +1 more source
Adeno-associated virus and hepatocytes: frenemies? [PDF]
Pierce GF.
europepmc +1 more source

